APA (7th ed.) Citation

BK, A., KJ, B., L, Q., LS, S., S, Q., JE, T., . . . HF, T. (2024). Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages. Human vaccines & immunotherapeutics, 20(1), 2335052. https://doi.org/10.1080/21645515.2024.2335052

Chicago Style (17th ed.) Citation

BK, Ackerson, et al. "Effectiveness and Durability of MRNA-1273 BA.4/BA.5 Bivalent Vaccine (mRNA-1273.222) Against SARS-CoV-2 BA.4/BA.5 and XBB Sublineages." Human Vaccines & Immunotherapeutics 20, no. 1 (2024): 2335052. https://doi.org/10.1080/21645515.2024.2335052.

MLA (9th ed.) Citation

BK, Ackerson, et al. "Effectiveness and Durability of MRNA-1273 BA.4/BA.5 Bivalent Vaccine (mRNA-1273.222) Against SARS-CoV-2 BA.4/BA.5 and XBB Sublineages." Human Vaccines & Immunotherapeutics, vol. 20, no. 1, 2024, p. 2335052, https://doi.org/10.1080/21645515.2024.2335052.